natgillin/translations-raw huggingface dataset:
Your doctor will normally advise you to stop taking Copalia before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Copalia. 
Liječnik će Vas u pravilu savjetovati da prekinete uzimati Copaliu prije trudnoće ili čim saznate da ste trudni te će Vas savjetovati da uzmete drugi lijek umjesto Copalie.
Over 1,400 hypertensive patients received Copalia once daily in two placebo-controlled trials. 
Više od 1400 hipertenzivnih bolesnika primalo je Copaliu jednom dnevno u dva placebo kontrolirana klinička ispitivanja.
Do not take Copalia if you are allergic to amlodipine or to any other calcium channel blockers. 
Nemojte uzimati Copaliu ako ste alergični na amlodipin ili na bilo koji drugi blokator kalcijevih kanala.
What Copalia contains 
Što Copalia sadrži
If you think you may be allergic, talk to your doctor before taking Copalia. 
Ako mislite da biste mogli biti alergični, porazgovarajte sa svojim liječnikom prije uzimanja Copalie.
The safety and efficacy of Copalia in children aged below 18 years have not been established. 
Sigurnost i djelotvornost Copalie u djece u dobi ispod 18 godina nisu ustanovljene.
What you need to know before you take Copalia 
Što morate znati prije nego počnete uzimati Copaliu
What Copalia is and what it is used for What you need to know before you take Copalia How to take Copalia 
Što je Copalia i za što se koristi Što morate znati prije nego počnete uzimati Copaliu Kako uzimati Copaliu
The usual dose of Copalia is one tablet per day. 
Uobičajena doza Copalie je jedna tableta na dan.
If a diurectic is also used, the risk of lithium toxicity may presumably be increased further with Copalia. 
Ako se diuretik također koristi, rizik od toksičnosti litija vjerojatno se može povećati i više s Copaliom.
Age, gender, race or body mass index (≥30 kg/m 2, <30 kg/m 2) did not influence the response to 
Dob, spol, rasa ili indeks tjelesne mase (≥30 kg/m2, <30 kg/m2) nisu utjecali na odgovor na Copaliu.
To date there is no experience of the safe use of Copalia in patients who have had a recent kidney transplantation. 
Do danas ne postoji iskustvo o sigurnoj primjeni Copalie u bolesnika kojima je nedavno transplantiran bubreg.
Date of first authorisation: 16 January.2007 Date of latest renewal: 21 November 2011 
Datum prvog odobrenja: 16. siječanj 2007.
Correction of this condition prior to administration of Copalia or close medical supervision at the start of treatment is recommended. 
Preporučuje se korigiranje ovog stanja prije primjene Copalie ili pažljiv liječnički nadzor na početku liječenja.
Do not take Copalia with grapefruit or grapefruit juice. 
Ne uzimajte Copaliu s grejpom ili sokom od grejpa.
Children and adolescents The use of Copalia in children and adolescents is not recommended (aged below 18 years old). 
Primjena Copalie u djece i adolescenata se ne preporučuje (ispod 18 godina starosti).
Other possible side effects of Copalia: 
Ostale moguće nuspojave Copalie:
The recommended dose of Copalia is one tablet per day. 
Preporučena doza Copalie je jedna tableta na dan.
If you stop taking Copalia 
Ako prestanete uzimati Copaliu
Patients taking Copalia and driving vehicles or using machines should take into account that dizziness or weariness may occasionally occur. 
Bolesnici koji uzimaju Copaliu i upravljaju vozilima ili rade na strojevima trebaju imati na umu da se katkada mogu javiti omaglica ili iscrpljenost.
Stopping your treatment with Copalia may cause your disease to get worse. 
Prestanak liječenja Copaliom može dovesti do pogoršanja bolesti od koje bolujete.
Copalia is not recommended for mothers who are breastfeeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely. 
Copalia se ne preporučuje majkama koje doje, a ako želite dojiti liječnik Vam može odabrati drugo liječenje, posebno ako je Vaše dijete novorođenče ili je prijevremeno rođeno.
You can take Copalia with or without food. 
Copaliu možete uzimati s hranom ili bez nje.
Copalia has not been studied in any patient population other than hypertension. 
Copalia nije ispitivan ni u jednoj drugoj populaciji bolesnika, osim u bolesnika s hipertenzijom.
Copalia can be used with or without food. 
Copalia se može primjenjivati s hranom ili bez nje.
The safety of Copalia has been evaluated in five controlled clinical studies with 5,175 patients, 2,613 of whom received valsartan in combination with amlodipine. 
Sigurnost Copalie je ispitivana u pet kontroliranih kliničkih ispitivanja s 5175 bolesnika, od kojih je 2613 primalo valsartan u kombinaciji s amlodipinom.
If you get these symptoms, stop taking Copalia and contact your doctor straight away. 
Ako dobijete ove simptome, prekinite uzimati Copaliu i odmah se javite svom liječniku.
If you forget to take Copalia 
Ako ste zaboravili uzeti Copaliu
No drug-drug interaction studies have been performed with Copalia and other medicinal products. 
Nisu provedena ispitivanja interakcija među lijekovima s Copaliom i drugim lijekovima.
Copalia combines two antihypertensive compounds with complementary mechanisms to control blood pressure in patients with essential hypertension: amlodipine belongs to the calcium antagonist class and valsartan to the angiotensin II antagonist class of medicines. 
Copalia kombinira dva antihipertenzivna sastojka s komplementarnim mehanizmima kontrole krvnog tlaka u bolesnika s esencijalnom hipertenzijom: amlodipin pripada skupini kalcijevih antagonista, dok valsartan pripada skupini antagonista angiotenzina II.
Copalia tablets contain two substances called amlodipine and valsartan. 
Copalia tablete sadrže dvije djelatne tvari koje se zovu amlodipin i valsartan.
Do not use any Copalia pack that is damaged or shows signs of tampering. 
Ne koristiti Copaliu ako primijetite da je pakovanje oštećeno ili su vidljivi znakovi otvaranja.
There is no experience of overdose with Copalia. 
Nema iskustva s predoziranjem Copaliom.
Copalia is available in packs containing 7, 14, 28, 30, 56, 90, 98 or 280 tablets and in multipacks comprising 4 cartons, each containing 70 tablets, or 20 cartons, each containing 14 tablets. 
Copalia je dostupna u pakiranjima koja sadrže 7, 14, 28, 30, 56, 90, 98 ili 280 tableta i u višestrukim pakiranjima koji sadrže 4 kutije, od kojih svaka sadrži 70 tableta, ili 20 kutija, od kojih svaka sadrži 14 tableta.
The rate and extent of absorption of Copalia are equivalent to the bioavailability of valsartan and amlodipine when administered as individual tablets. 
Brzina i opseg apsorpcije Copalie jednaki su bioraspoloživosti valsartana i amlodipina kada se primjenjuju kao pojedinačne tablete.
For convenience, patients receiving valsartan and amlodipine from separate tablets/capsules may be switched to Copalia containing the same component doses. 
Bolesnici koji primaju valsartan i amlodipin u odvojenim tabletama/kapsulama, mogu se radi jednostavnosti prebaciti na Copaliu koji sadrži iste doze sastojaka.
No information is available regarding the use of Copalia during breast-feeding, therefore Copalia is not recommended and alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a newborn or preterm infant. 
Budući da nisu dostupne informacije o primjeni Copalie tijekom dojenja, stoga se Copalia tijekom dojenja ne preporučuje te se savjetuje alternativno liječenje s bolje utvrđenim sigurnosnim profilom tijekom dojenja, posebno kod dojenja novorođenčeta ili nedonoščeta.
Abrupt withdrawal of Copalia has not been associated with a rapid increase in blood pressure. 
Nagli prekid primjene Copalie nije bio povezan s naglim povišenjem krvnog tlaka.
Clinically significant hypotension due to Copalia overdose calls for active cardiovascular support, including frequent monitoring of cardiac and respiratory function, elevation of extremities, and attention to circulating fluid volume and urine output. 
Klinički značajna hipotenzija zbog predoziranja Copaliom zahtijeva aktivnu kardiovaskularnu potporu, uključujući često praćenje srčane i respiratorne funkcije, podizanje ekstremiteta, uz praćenje volumena cirkulirajuće tekućine i mokrenja.
Copalia should be used with caution to treat hypertension in patients with unilateral or bilateral renal artery stenosis or stenosis to a solitary kidney since blood urea and serum creatinine may increase in such patients. 
Copalia se treba primjenjivati s oprezom u liječenju hipertenzije u bolesnika s jednostranom ili obostranom stenozom bubrežne arterije ili stenozom bubrežne arterije kod postojanja samo jednog bubrega budući da se u ovih bolesnika može povisiti urea u krvi i serumski kreatinin.
Copalia was also studied in an active-controlled study of 130 hypertensive patients with mean sitting diastolic blood pressure ≥110 mmHg and <120 mmHg. 
Copalia je također ispitivan u aktivno kontroliranom kliničkom ispitivanju sa 130 hipertenzivnih bolesnika sa srednjom vrijednošću dijastoličkog krvnog tlaka u sjedećem položaju ≥110 mmHg i <120 mmHg.
The amlodipine component of Copalia inhibits the transmembrane entry of calcium ions into cardiac and vascular smooth muscle. 
Amlodipinska komponenta Copalie inhibira transmembranski ulaz iona kalcija u srčani mišić i glatki mišić krvnih žila.
If hypotension occurs with Copalia, the patient should be placed in the supine position and, if necessary, given an intravenous infusion of normal saline. 
Ako se uz Copaliu pojavi hipotenzija, bolesnika treba poleći na leđa i po potrebi, mu dati intravensku infuziju fiziološke otopine.
Adverse reactions previously reported with one of the individual components (amlodipine or valsartan) may be potential adverse reactions with Copalia as well, even if not observed in clinical trials or during the post-marketing period. 
Dodatne informacije o pojedinačnim komponentama Nuspojave koje su ranije prijavljene s jednom od pojedinačnih komponenti (amlodipinom ili valsartanom) mogu biti i moguće nuspojave Copalie, iako nisu uočene u kliničkim ispitivanjima ili nakon stavljanja lijeka u promet.
• Concomitant use of Copalia with aliskiren-containing products in patients with diabetes mellitus or renal impairment (GFR <60 ml/min/1.73 m2) (see sections 4.5 and 5.1). 
• Istodobna primjena Copalie s lijekovima koji sadrže aliskiren kontraindicirana je u bolesnika sa šećernom bolešću ili oštećenjem bubrega (GFR <60 ml/min/1,73 m2) (vidjeti dijelove 4.5 i 5.1).
if you have severe liver problems or bile problems such as biliary cirrhosis or cholestasis. 
ako imate teške probleme s jetrom ili probleme sa žuči, poput bilijarne ciroze ili kolestaze.
If any of the above applies to you, do not take Copalia and talk to your doctor. 
Ako se bilo što od navedenog odnosi na Vas, nemojte uzeti Copaliu i obavijestite svog liječnika.
Frequency Copalia Amlodipine Valsartan 
Učestalost Copalia Amlodipin Valsartan
If any of these apply to you, tell your doctor before taking Copalia. 
Ako se bilo što od navedenog odnosi na Vas, obavijestite svog liječnika prije uzimanja Copalie.
Following oral administration of Copalia, peak plasma concentrations of valsartan and amlodipine are reached in 3 and 6-8 hours, respectively. 
Nakon peroralne primjene Copalie, vršne koncentracije amlodipina i valsartana u plazmi postižu se u 3 odnosno 6-8 sati.
Side effects reported with amlodipine or valsartan alone and either not observed with Copalia or observed with a higher frequency than with Copalia: 
Prijavljene nuspojave s amlodipinom ili valsartanom primjenjenima samostalno ili uopće nisu opažene s Copaliom ili su opažene s većom učestalošću nego s Copaliom:
ACE inhibitors or aliskiren (see also information under the headings “Do not take Copalia” and “Warnings and precautions”); diuretics (a type of medicine also called “water tablets” which increases the amount of urine you produce); lithium (a medicine used to treat some types of depression); potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium and other substances that may increase potassium levels; certain types of painkillers called non-steroidal anti-inflammatory medicines (NSAIDs) or selective cyclooxygenase-2 inhibitors (COX-2 inhibitors). 
ACE inhibitori ili aliskiren (vidjeti također informacije pod naslovom „Nemojte uzimati Copaliu“ i „Upozorenja i mjere opreza“); diuretici (vrsta lijeka koja se naziva i „tablete za mokrenje“ koje povećavaju količinu mokraće koju proizvodite); litij (lijek koji se koristi za liječenje nekih vrsta depresije); diuretici koji štede kalij, nadomjesci kalija, zamjene za sol koje sadrže kalij i ostale tvari koje mogu povećati razinu kalija; određene vrste lijekova protiv bolova koji se nazivaju nesteoridni protuupalni lijekovi (NSAILi) ili selektivnim inhibitorima ciklooksigenaze-2 (COX-2 inhibitori).
There are no clinical studies on fertility with Copalia. 
Ne postoje klinička ispitivanja djelovanja Copalie na plodnost.
Multipack: 280 (4 packs of 70) film-coated tablets Multipack: 280 (20 packs of 14) film-coated tablets 
Višestruko pakovanje: 280 (4 pakiranja od 70) filmom obloženih tableta Višestruko pakovanje: 280 (20 pakiranja od 14) filmom obloženih tableta
if you are taking any of the following medicines used to treat high blood pressure: 
ako uzimate bilo koji od lijekova navedenih u nastavku, koji se koriste za liječenje visokog krvnog tlaka:
Talk to your doctor before taking Copalia: if you have been sick (vomiting or diarrhoea). 
Obratite se svom liječniku prije nego uzmete Copaliu: ako ste bili bolesni (povraćanje ili proljev).
Hepatic impairment Copalia is contraindicated in patients with severe hepatic impairment (see section 4.3). 
Oštećenje jetre Copalia je kontraindiciran u bolesnika s teškim oštećenjem jetre (vidjeti dio 4.3).
How to take Copalia 
Kako uzimati Copaliu
In this study (baseline blood pressure 171/113 mmHg), a Copalia regimen of 5 mg/160 mg titrated to 10 mg/160 mg reduced sitting blood pressure by 36/29 mmHg as compared to 32/28 mmHg with a regimen of lisinopril/hydrochlorothiazide 10 mg/12.5 mg titrated to 20 mg/12.5 mg. 
U tom ispitivanju (početni krvni tlak 171/113 mmHg), liječenje Copaliom 5 mg/160 mg titriranim do 10 mg/160 mg snizilo je krvni tlak u sjedećem položaju za 36/29 mmHg, u usporedbi s 32/28 mmHg kod liječenja lizinoprilom/hidroklorotiazidom 10 mg/12,5 mg titriranim do 20 mg/12,5 mg.
Copalia should be discontinued immediately in patients who develop angioedema and should not be re-administered. 
Bolesnici u kojih se razvije angioedem trebaju odmah prekinuti primjenu Copalie i više ga ne smiju ponovo uzimati.
Copalia is indicated in adults whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy. 
Copalia je indiciran u odraslih osoba čiji krvni tlak nije odgovarajuće kontroliran monoterapijom amlodipinom ili valsartanom.
Copalia is used to treat high blood pressure in adults whose blood pressure is not controlled enough with either amlodipine or valsartan on its own. 
Copalia se primjenjuje za liječenje povišenog krvnog tlaka u odraslih osoba čiji krvni tlak nije dovoljno kontroliran bilo samo amlodipinom ili samo valsartanom.
When switching eligible elderly hypertensive patients (see section 4.1) to amlodipine or Copalia, the lowest available dose of amlodipine monotherapy or of the amlodipine component, respectively, should be used. 
Prilikom prebacivanja starijih hipertenzivnih bolesnika koji ispunjavaju uvjete za liječenje (vidjeti dio 4.1) na amlodipin ili Copaliu, treba se koristiti najniža dostupna doza amlodipina u monoterapiji ili amlodipina kao komponente.
Excessive hypotension was seen in 0.4% of patients with uncomplicated hypertension treated with Copalia in placebo-controlled studies. 
U placebo-kontroliranim ispitivanjima, u 0,4% bolesnika s nekompliciranom hipertenzijom liječenih Copaliom viđena je izražena hipotenzija.
How to store Copalia 
Kako čuvati Copaliu
Copalia 5 mg/80 mg may be administered in patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg alone. 
Copalia 5 mg/80 mg se može primjenjivati u bolesnika čiji krvni tlak nije odgovarajuće kontroliran samo amlodipinom 5 mg ili valsartanom 80 mg.
Particular caution should be exercised when administering Copalia to patients with mild to moderate hepatic impairment or biliary obstructive disorders. 
Nužan je poseban oprez kod primjene Copalie bolesnicima s blagim do umjerenim oštećenjem jetre ili opstruktivnim poremećajima žučnog sustava.
Caution should be exercised when administering Copalia to patients with hepatic impairment or biliary obstructive disorders (see section 4.4). 
Nužan je oprez kod primjene Copalie bolesnicima s oštećenjem jetre ili opstruktivnim bolestima žučnog sustava (vidjeti dio 4.4).
When switching eligible hypertensive patients (see section 4.1) with hepatic impairment to amlodipine or Copalia, the lowest available dose of amlodipine monotherapy or of the amlodipine component, respectively, should be used. 
Prilikom prebacivanja hipertenzivnih bolesnika koji ispunjavaju uvjete za liječenje (vidjeti dio 4.1) s oštećenjem jetre na amlodipin ili Copaliu, treba se koristiti najniža dostupna doza amlodipina u monoterapiji ili amlodipina kao komponente.
Copalia 5 mg/160 mg may be administered in patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg alone. 
Copalia 5 mg/160 mg se može primjenjivati u bolesnika čiji krvni tlak nije odgovarajuće kontroliran samo amlodipinom 5 mg ili valsartanom 160 mg.
This is because grapefruit and grapefruit juice can lead to an increase in the blood levels of the active substance amlodipine, which can cause an unpredictable increase in the blood pressure lowering effect of Copalia. 
Grejp i sok od grejpa u nekih bolesnika može dovesti do povećanja razina djelatne tvari amlodipina u krvi, što može uzrokovati neočekivano pojačani učinak na snižavanje krvnog tlaka.
No dosage adjustment of Copalia is required for patients with mild to moderate renal impairment (GFR >30 ml/min/1.73 m2). 
U bolesnika s blagim do umjerenim oštećenjem bubrega (GFR >30 ml/min/1,73 m2) doziranje Copalie nije potrebno prilagođavati.
Copalia 10 mg/160 mg tablets are oval and light yellow with “NVR” on one side and “UIC” on the other side. 
Copalia 10 mg/160 mg tablete su ovalne, svijetložute tablete, s oznakom „NVR“ na jednoj strani i „UIC“ na drugoj strani.
Copalia 5 mg/80 mg film-coated tablets Copalia 5 mg/160 mg film-coated tablets Copalia 10 mg/160 mg film-coated tablets 
Copalia 5 mg/80 mg filmom obložene tablete Copalia 5 mg/160 mg filmom obložene tablete Copalia 10 mg/160 mg filmom obložene tablete
Copalia 5 mg/160 mg tablets are oval and dark yellow “NVR” on one side and “ECE” on the other side. 
Copalia 5 mg/160 mg tablete su ovalne, tamnožute tablete, s oznakom „NVR“ na jednoj strani i „ECE“ na drugoj strani.
Copalia 5 mg/80 mg film-coated tablets Copalia 5 mg/160 mg film-coated tablets Copalia 10 mg/160 mg film-coated tablets amlodipine/valsartan 
Copalia 5 mg/80 mg filmom obložene tablete Copalia 5 mg/160 mg filmom obložene tablete Copalia 10 mg/160 mg filmom obložene tablete amlodipin/valsartan
Copalia 5 mg/80 mg film-coated tablets 
Copalia 5 mg/80 mg filmom obložene tablete
Copalia 10 mg/160 mg film-coated tablets 
Copalia 10 mg/160 mg filmom obložene tablete
EU/1/06/372/035 280 film-coated tablets (4x70) EU/1/06/372/038 280 film-coated tablets (20x14) 
EU/1/06/372/035 280 filmom obloženih tableta (4x70) EU/1/06/372/038 280 filmom obloženih tableta (20x14)
Grapefruit and grapefruit juice should not be consumed by people who are taking Copalia. 
Bolesnici koji uzimaju Copaliu ne smiju konzumirati grejp ili sok od grejpa.
EU/1/06/372/036 280 film-coated tablets (4x70) EU/1/06/372/039 280 film-coated tablets (20x14) 
EU/1/06/372/036 280 filmom obloženih tableta (4x70) EU/1/06/372/039 280 filmom obloženih tableta (20x14)
Copalia 5 mg/160 mg film-coated tablets 
Copalia 5 mg/160 mg filmom obložene tablete
EU/1/06/372/034 280 film-coated tablets (4x70) EU/1/06/372/037 280 film-coated tablets (20x14) 
EU/1/06/372/034 280 filmom obloženih tableta (4x70) EU/1/06/372/037 280 filmom obloženih tableta (20x14)
Copalia 5 mg/80 mg film-coated tablets amlodipine/valsartan 
Copalia 5 mg/80 mg filmom obložene tablete amlodipin/valsartan
Copalia 10 mg/160 mg film-coated tablets amlodipine/valsartan 
Copalia 10 mg/160 mg filmom obložene tablete amlodipin/valsartan
Copalia 5 mg/160 mg film-coated tablets amlodipine/valsartan 
Copalia 5 mg/160 mg filmom obložene tablete amlodipin/valsartan
EU/1/06/372/017 7 film-coated tablets EU/1/06/372/018 14 film-coated tablets EU/1/06/372/019 28 film-coated tablets EU/1/06/372/020 30 film-coated tablets EU/1/06/372/021 56 film-coated tablets EU/1/06/372/022 90 film-coated tablets EU/1/06/372/023 98 film-coated tablets EU/1/06/372/024 280 film-coated tablets EU/1/06/372/031 56x1 film-coated tablet (unit dose) EU/1/06/372/032 98x1 film-coated tablet (unit dose) EU/1/06/372/033 280x1 film-coated tablet (unit dose) 
EU/1/06/372/017 7 filmom obloženih tableta EU/1/06/372/018 14 filmom obloženih tableta EU/1/06/372/019 28 filmom obloženih tableta EU/1/06/372/020 30 filmom obloženih tableta EU/1/06/372/021 56 filmom obloženih tableta EU/1/06/372/022 90 filmom obloženih tableta EU/1/06/372/023 98 filmom obloženih tableta EU/1/06/372/024 280 filmom obloženih tableta EU/1/06/372/031 56x1 filmom obloženih tableta (jedinična doza) EU/1/06/372/032 98x1 filmom obloženih tableta (jedinična doza) EU/1/06/372/033 280x1 filmom obloženih tableta (jedinična doza)
EU/1/06/372/001 7 film-coated tablets EU/1/06/372/002 14 film-coated tablets EU/1/06/372/003 28 film-coated tablets EU/1/06/372/004 30 film-coated tablets EU/1/06/372/005 56 film-coated tablets EU/1/06/372/006 90 film-coated tablets EU/1/06/372/007 98 film-coated tablets EU/1/06/372/008 280 film-coated tablets EU/1/06/372/025 56x1 film-coated tablet (unit dose) EU/1/06/372/026 98x1 film-coated tablet (unit dose) EU/1/06/372/027 280x1 film-coated tablet (unit dose) 
EU/1/06/372/001 7 filmom obloženih tableta EU/1/06/372/002 14 filmom obloženih tableta EU/1/06/372/003 28 filmom obloženih tableta EU/1/06/372/004 30 filmom obloženih tableta EU/1/06/372/005 56 filmom obloženih tableta EU/1/06/372/006 90 filmom obloženih tableta EU/1/06/372/007 98 filmom obloženih tableta EU/1/06/372/008 280 filmom obloženih tableta EU/1/06/372/025 56x1 filmom obloženih tableta (jedinična doza) EU/1/06/372/026 98x1 filmom obloženih tableta (jedinična doza) EU/1/06/372/027 280x1 filmom obloženih tableta (jedinična doza)
What Copalia looks like and contents of the pack Copalia 5 mg/80 mg tablets are round and dark yellow with “NVR” on one side and “NV” on the other side. 
Copalia 5 mg/80 mg tablete su okrugle, tamnožute tablete, s oznakom „NVR“ na jednoj strani i „NV“ na drugoj strani.
EU/1/06/372/009 7 film-coated tablets EU/1/06/372/010 14 film-coated tablets EU/1/06/372/011 28 film-coated tablets EU/1/06/372/012 30 film-coated tablets EU/1/06/372/013 56 film-coated tablets EU/1/06/372/014 90 film-coated tablets EU/1/06/372/015 98 film-coated tablets EU/1/06/372/016 280 film-coated tablets EU/1/06/372/028 56x1 film-coated tablet (unit dose) EU/1/06/372/029 98x1 film-coated tablet (unit dose) EU/1/06/372/030 280x1 film-coated tablet (unit dose) 
EU/1/06/372/009 7 filmom obloženih tableta EU/1/06/372/010 14 filmom obloženih tableta EU/1/06/372/011 28 filmom obloženih tableta EU/1/06/372/012 30 filmom obloženih tableta EU/1/06/372/013 56 filmom obloženih tableta EU/1/06/372/014 90 filmom obloženih tableta EU/1/06/372/015 98 filmom obloženih tableta EU/1/06/372/016 280 filmom obloženih tableta EU/1/06/372/028 56x1 filmom obloženih tableta (jedinična doza) EU/1/06/372/029 98x1 filmom obloženih tableta (jedinična doza) EU/1/06/372/030 280x1 filmom obloženih tableta (jedinična doza)